alk genetic mutations that are studied in lung adenocarcinoma
The present study was carried out to detect the prevalence of EGFR mutations and EML4-ALK fusions in EGFR mutation-negative cases of NSCLC (adenocarcinoma) as well as to evaluate the clinical characteristics of EGFR mutations and EML4-ALK fusions in EGFR mutation-negative cases of NSCLC.
By Dave Levitan. A common genetic mutation appears to play a role in resistance to tyrosine kinase inhibitors among certain types of cancer, including chronic myeloid leukemia (CML) and EGFR-mutated nonâsmall-cell lung cancer (NSCLC), according to a new study.y Dave Levitan. A common genetic mutation appears to play a role in resistance to tyrosine kinase inhibitors among certain types of cancer, including chronic myeloid leukemia (CML) and EGFR-mutated nonâsmall-cell lung cancer (NSCLC), according to a new study.